Lewy Body Dementia Market Expected To Witness Revenue Growth Toward $1.68 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Forecasted Market Size Figures For The Lewy Body Dementia Market In 2026 And 2030?

The lewy body dementia market size has experienced substantial growth in recent years. It is projected to increase from $1.2 billion in 2025 to $1.29 billion in 2026, at a compound annual growth rate (CAGR) of 7.2%. The expansion witnessed in the historic period can be ascribed to an aging population, improved recognition of dementia subtypes, the increasing application of neurological examinations, the broadening scope of hospital-based diagnosis, and a heightened clinical focus on cognitive decline.

The lewy body dementia market size anticipates robust expansion in the coming years, reaching $1.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is propelled by factors such as enhanced diagnostic precision, an increasing prevalence of chronic neurological conditions, the expansion of specialized clinic networks, boosted support initiatives for caregivers and patients, and elevated healthcare expenditure dedicated to dementia care. Key trends expected during the same period encompass the growing incidence of neurodegenerative disorders, heightened awareness and earlier identification of LBD, a greater imperative for precise differential diagnosis, broader application of symptom-specific medications, and an escalating requirement for sustained care and disease management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp

What Core Drivers Are Transforming The Lewy Body Dementia Market?

The escalating occurrence of brain-related conditions is anticipated to fuel the expansion of the lewy body dementia market. These disorders encompass various ailments impacting the brain’s structure and operations, resulting in impaired cognition, memory loss, and altered behavior. Their prevalence is on the rise, attributed to elements like aging, genetic susceptibilities, and environmental factors. This growing prevalence intensifies the need for improved treatments and prompt diagnosis of lewy body dementia, thereby stimulating research, investment, and breakthroughs that accelerate progress in LBD diagnosis and therapy. An illustration of this trend is seen in October 2023, when the World Federation of Neurology, the UK-based association of national neurological societies, reported that neurological conditions affect more than 40% of the global population, a figure projected to almost double by 2050. Consequently, the escalating incidence of brain-related disorders will propel the growth of the lewy body dementia market.

What Key Segment Areas Are Included In The Lewy Body Dementia Market Assessment?

The lewy body dementia market covered in this report is segmented –

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)

Which Trends Are Shaping The Lewy Body Dementia Market Landscape?

Key companies active in the Lewy Body Dementia market are channeling efforts into research funding to create more effective treatments for neurodegenerative conditions. Research investment involves committing financial resources, time, and dedicated effort to scientific and technological investigations aimed at revealing new insights, developing inventive solutions, or improving existing methods. This type of investment supports the exploration of diseases and the creation of novel medications, all with the primary objective of enhancing patient outcomes. An illustration of this is from March 2023, when the National Institute on Aging, a US-based government entity, awarded $21 million to fund drug development research specifically for Lewy Body Dementia (LBD). Following encouraging preliminary findings, researchers at the University of Miami Miller School of Medicine are launching a Phase 2b study for neflamapimod.

Which Organizations Are Operating Within The Lewy Body Dementia Market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer’s Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

Access The Complete Lewy Body Dementia Market Report:

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report

Which Region Holds The Largest Share In The Lewy Body Dementia Market?

North America was the largest region in the lewy body dementia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lewy Body Dementia Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21213&type=smp

Browse Through More Reports Similar to the Global Lewy Body Dementia Market 2026, By The Business Research Company

Alzheimers Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Alzheimers Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Elderly Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/elderly-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795